Remifentanil의 목표농도조절주입을 이용한 propofol 정주통의 경감
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 남유미 | - |
dc.contributor.author | 변장원 | - |
dc.contributor.author | 권구민 | - |
dc.contributor.author | 김용오 | - |
dc.contributor.author | 이재민 | - |
dc.contributor.author | 전우재 | - |
dc.date.accessioned | 2022-07-16T06:21:14Z | - |
dc.date.available | 2022-07-16T06:21:14Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2014-01 | - |
dc.identifier.issn | 1975-5171 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/160849 | - |
dc.description.abstract | Background: Propofol has a high incidence of infusion pain. Wehypothesized that propofol infusion pain might be prevented byinfusing remifentanil before starting the propofol infusion in a clinicalsetting where target controlled infusions (TCI) of both drugs wereused. We compared the efficacy of remifentanil TCI administered90 seconds before propofol TCI with remifentanil TCI and propofolTCI given immediately after a 40 mg lidocaine bolus in preventionof propofol infusion pain. Methods: One hundred sixty five ASA 1 or 2 patients scheduledfor elective surgery under general anesthesia were classified inthree groups. Group C: propofol TCI and remifentanil TCI wasstarted at the same time (n = 55), group L: lidocaine 40 mg injectionimmediately prior to propofol TCI and remifentanil TCI (n = 55),group R: remifentanil TCI was started 90 seconds before propofolTCI (n = 55). Pain severity of propofol infusion was evaluated usinga four-point scale (none, mild, moderate, severe). Results: The incidence of pain in group R and group L wassignificantly lower than in group C. There was no significantdifference between group R and group L. But the incidence ofmoderate and severe pain in group R was significantly lower thanin group L (P < 0.05). Conclusions: Remifentanil TCI 90 seconds before propofol TCIreduces propofol infusion pain than propofol TCI and remifentanilTCI started at the same time. This protocol is considered to be moreeffective in alleviating moderate and severe pain than lidocaine. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한마취통증의학회 | - |
dc.title | Remifentanil의 목표농도조절주입을 이용한 propofol 정주통의 경감 | - |
dc.title.alternative | Reduction of propofol infusion pain using target controlled infusion of remifentanil | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 전우재 | - |
dc.identifier.bibliographicCitation | Anesthesia and Pain Medicine, v.9, no.1, pp.36 - 40 | - |
dc.relation.isPartOf | Anesthesia and Pain Medicine | - |
dc.citation.title | Anesthesia and Pain Medicine | - |
dc.citation.volume | 9 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 36 | - |
dc.citation.endPage | 40 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001846401 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Infusion pain | - |
dc.subject.keywordAuthor | Lidocaine | - |
dc.subject.keywordAuthor | Propofol | - |
dc.subject.keywordAuthor | Remifentanil | - |
dc.subject.keywordAuthor | Target controlled infusion | - |
dc.identifier.url | https://www.anesth-pain-med.org/journal/view.php?number=402 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.